Cleo Diagnostics (ASX:COV) OCF Margin %: 0.00% (As of Dec. 2025)


ASX:COV Cleo Diagnostics Ltd ASX:COV
17 GF Score
Price A$0.48
! 1 Warning Sign
View Full Analysis

What is Cleo Diagnostics OCF Margin %?

Cleo Diagnostics ASX:COV 17 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:COV with a GF Score™ of 17/100. The stock has 1 warning sign investors should review. Among 815 Medical Devices & Instruments companies, Cleo Diagnostics ranks worse than 122699.26% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cleo Diagnostics's Cash Flow from Operations for the six months ended in Dec. 2025 was A$-1.67 Mil. Cleo Diagnostics's Revenue for the six months ended in Dec. 2025 was A$0.00 Mil. Therefore, Cleo Diagnostics's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Cleo Diagnostics's current OCF Yield % is -3.73%.

The historical rank and industry rank for Cleo Diagnostics's OCF Margin % or its related term are showing as below:


ASX:COV's OCF Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 5.86
* Ranked among companies with meaningful OCF Margin % only.

Cleo Diagnostics OCF Margin % Related Terms

Cleo Diagnostics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cleo Diagnostics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cleo Diagnostics OCF Margin % Chart

Cleo Diagnostics Annual Data
Trend Jun23 Jun24 Jun25
OCF Margin %
0.00 0.00 0.00

Cleo Diagnostics Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
ASX:COV
17GF Score
Cleo Diagnostics Ltd ASX:COV
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cleo Diagnostics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cleo Diagnostics's OCF Margin for the fiscal year that ended in Jun. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Jun. 2025 )/Revenue (A: Jun. 2025 )
=-2.901/0
= %

Cleo Diagnostics's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-1.668/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Cleo Diagnostics (ASX:COV) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cleo Diagnostics and its competitors. According to the industry distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry.
Is Cleo Diagnostics' OCF Margin % too high?
Cleo Diagnostics' current OCF Margin % is 0.00%. Based on the distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cleo Diagnostics has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Cleo Diagnostics' OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cleo Diagnostics ranks #999999 out of 815 companies for OCF Margin %. This places Cleo Diagnostics in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cleo Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cleo Diagnostics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleo Diagnostics stock overvalued right now?
Cleo Diagnostics (ASX:COV) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Cleo Diagnostics' overall GF Score™ is 17/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cleo Diagnostics (ASX:COV), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cleo Diagnostics Business Description

Address 480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000
Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company's first product to market is intended to be the Triage Test which results to accurately differentiate patients with malignant ovarian cancer from those with benign gynecological conditions. The company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.
17GF Score

Get the complete analysis for ASX:COV

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.48
Price